Duloxetine Market, Global Outlook and Forecast 2022-2028

March 2022 | 60 pages | ID: DF87AFB80397EN
Market Monitor Global

Abstracts

Duloxetine, sold under the brand name Cymbalta among others, is a medication mostly used for major depressive disorder, generalized anxiety disorder, fibromyalgia, and neuropathic pain.

This report contains market size and forecasts of Duloxetine in Global, including the following market information:

Global Duloxetine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Duloxetine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

20mg Capsules Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Duloxetine include Eli Lilly, Teva, Lupin, Sun Pharma, Zydus Pharmaceuticals, Torrent Pharmaceuticals, Sandoz, Aurobindo Pharma and Apotex, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Duloxetine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Duloxetine Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Duloxetine Market Segment Percentages, by Type, 2021 (%)

• 20mg Capsules
• 30mg Capsules
• 40mg Capsules
• 60mg Capsules

Global Duloxetine Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Duloxetine Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Drug store

Global Duloxetine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Duloxetine Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Duloxetine revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Duloxetine revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Eli Lilly
• Teva
• Lupin
• Sun Pharma
• Zydus Pharmaceuticals
• Torrent Pharmaceuticals
• Sandoz
• Aurobindo Pharma
• Apotex
• Breckenridge
• MACLEODS
• Ajanta Pharma
• CSPC Ouyi Pharm
• Jiangsu Nhwa Pharmaceutical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Duloxetine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Duloxetine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DULOXETINE OVERALL MARKET SIZE

2.1 Global Duloxetine Market Size: 2021 VS 2028
2.2 Global Duloxetine Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Duloxetine Players in Global Market
3.2 Top Global Duloxetine Companies Ranked by Revenue
3.3 Global Duloxetine Revenue by Companies
3.4 Top 3 and Top 5 Duloxetine Companies in Global Market, by Revenue in 2021
3.5 Global Companies Duloxetine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Duloxetine Players in Global Market
  3.6.1 List of Global Tier 1 Duloxetine Companies
  3.6.2 List of Global Tier 2 and Tier 3 Duloxetine Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Duloxetine Market Size Markets, 2021 & 2028
  4.1.2 20mg Capsules
  4.1.3 30mg Capsules
  4.1.4 40mg Capsules
  4.1.5 60mg Capsules
4.2 By Type - Global Duloxetine Revenue & Forecasts
  4.2.1 By Type - Global Duloxetine Revenue, 2017-2022
  4.2.2 By Type - Global Duloxetine Revenue, 2023-2028
  4.2.3 By Type - Global Duloxetine Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Duloxetine Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Drug store
5.2 By Application - Global Duloxetine Revenue & Forecasts
  5.2.1 By Application - Global Duloxetine Revenue, 2017-2022
  5.2.2 By Application - Global Duloxetine Revenue, 2023-2028
  5.2.3 By Application - Global Duloxetine Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Duloxetine Market Size, 2021 & 2028
6.2 By Region - Global Duloxetine Revenue & Forecasts
  6.2.1 By Region - Global Duloxetine Revenue, 2017-2022
  6.2.2 By Region - Global Duloxetine Revenue, 2023-2028
  6.2.3 By Region - Global Duloxetine Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Duloxetine Revenue, 2017-2028
  6.3.2 US Duloxetine Market Size, 2017-2028
  6.3.3 Canada Duloxetine Market Size, 2017-2028
  6.3.4 Mexico Duloxetine Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Duloxetine Revenue, 2017-2028
  6.4.2 Germany Duloxetine Market Size, 2017-2028
  6.4.3 France Duloxetine Market Size, 2017-2028
  6.4.4 U.K. Duloxetine Market Size, 2017-2028
  6.4.5 Italy Duloxetine Market Size, 2017-2028
  6.4.6 Russia Duloxetine Market Size, 2017-2028
  6.4.7 Nordic Countries Duloxetine Market Size, 2017-2028
  6.4.8 Benelux Duloxetine Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Duloxetine Revenue, 2017-2028
  6.5.2 China Duloxetine Market Size, 2017-2028
  6.5.3 Japan Duloxetine Market Size, 2017-2028
  6.5.4 South Korea Duloxetine Market Size, 2017-2028
  6.5.5 Southeast Asia Duloxetine Market Size, 2017-2028
  6.5.6 India Duloxetine Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Duloxetine Revenue, 2017-2028
  6.6.2 Brazil Duloxetine Market Size, 2017-2028
  6.6.3 Argentina Duloxetine Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Duloxetine Revenue, 2017-2028
  6.7.2 Turkey Duloxetine Market Size, 2017-2028
  6.7.3 Israel Duloxetine Market Size, 2017-2028
  6.7.4 Saudi Arabia Duloxetine Market Size, 2017-2028
  6.7.5 UAE Duloxetine Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Eli Lilly
  7.1.1 Eli Lilly Corporate Summary
  7.1.2 Eli Lilly Business Overview
  7.1.3 Eli Lilly Duloxetine Major Product Offerings
  7.1.4 Eli Lilly Duloxetine Revenue in Global Market (2017-2022)
  7.1.5 Eli Lilly Key News
7.2 Teva
  7.2.1 Teva Corporate Summary
  7.2.2 Teva Business Overview
  7.2.3 Teva Duloxetine Major Product Offerings
  7.2.4 Teva Duloxetine Revenue in Global Market (2017-2022)
  7.2.5 Teva Key News
7.3 Lupin
  7.3.1 Lupin Corporate Summary
  7.3.2 Lupin Business Overview
  7.3.3 Lupin Duloxetine Major Product Offerings
  7.3.4 Lupin Duloxetine Revenue in Global Market (2017-2022)
  7.3.5 Lupin Key News
7.4 Sun Pharma
  7.4.1 Sun Pharma Corporate Summary
  7.4.2 Sun Pharma Business Overview
  7.4.3 Sun Pharma Duloxetine Major Product Offerings
  7.4.4 Sun Pharma Duloxetine Revenue in Global Market (2017-2022)
  7.4.5 Sun Pharma Key News
7.5 Zydus Pharmaceuticals
  7.5.1 Zydus Pharmaceuticals Corporate Summary
  7.5.2 Zydus Pharmaceuticals Business Overview
  7.5.3 Zydus Pharmaceuticals Duloxetine Major Product Offerings
  7.5.4 Zydus Pharmaceuticals Duloxetine Revenue in Global Market (2017-2022)
  7.5.5 Zydus Pharmaceuticals Key News
7.6 Torrent Pharmaceuticals
  7.6.1 Torrent Pharmaceuticals Corporate Summary
  7.6.2 Torrent Pharmaceuticals Business Overview
  7.6.3 Torrent Pharmaceuticals Duloxetine Major Product Offerings
  7.6.4 Torrent Pharmaceuticals Duloxetine Revenue in Global Market (2017-2022)
  7.6.5 Torrent Pharmaceuticals Key News
7.7 Sandoz
  7.7.1 Sandoz Corporate Summary
  7.7.2 Sandoz Business Overview
  7.7.3 Sandoz Duloxetine Major Product Offerings
  7.7.4 Sandoz Duloxetine Revenue in Global Market (2017-2022)
  7.7.5 Sandoz Key News
7.8 Aurobindo Pharma
  7.8.1 Aurobindo Pharma Corporate Summary
  7.8.2 Aurobindo Pharma Business Overview
  7.8.3 Aurobindo Pharma Duloxetine Major Product Offerings
  7.8.4 Aurobindo Pharma Duloxetine Revenue in Global Market (2017-2022)
  7.8.5 Aurobindo Pharma Key News
7.9 Apotex
  7.9.1 Apotex Corporate Summary
  7.9.2 Apotex Business Overview
  7.9.3 Apotex Duloxetine Major Product Offerings
  7.9.4 Apotex Duloxetine Revenue in Global Market (2017-2022)
  7.9.5 Apotex Key News
7.10 Breckenridge
  7.10.1 Breckenridge Corporate Summary
  7.10.2 Breckenridge Business Overview
  7.10.3 Breckenridge Duloxetine Major Product Offerings
  7.10.4 Breckenridge Duloxetine Revenue in Global Market (2017-2022)
  7.10.5 Breckenridge Key News
7.11 MACLEODS
  7.11.1 MACLEODS Corporate Summary
  7.11.2 MACLEODS Business Overview
  7.11.3 MACLEODS Duloxetine Major Product Offerings
  7.11.4 MACLEODS Duloxetine Revenue in Global Market (2017-2022)
  7.11.5 MACLEODS Key News
7.12 Ajanta Pharma
  7.12.1 Ajanta Pharma Corporate Summary
  7.12.2 Ajanta Pharma Business Overview
  7.12.3 Ajanta Pharma Duloxetine Major Product Offerings
  7.12.4 Ajanta Pharma Duloxetine Revenue in Global Market (2017-2022)
  7.12.5 Ajanta Pharma Key News
7.13 CSPC Ouyi Pharm
  7.13.1 CSPC Ouyi Pharm Corporate Summary
  7.13.2 CSPC Ouyi Pharm Business Overview
  7.13.3 CSPC Ouyi Pharm Duloxetine Major Product Offerings
  7.13.4 CSPC Ouyi Pharm Duloxetine Revenue in Global Market (2017-2022)
  7.13.5 CSPC Ouyi Pharm Key News
7.14 Jiangsu Nhwa Pharmaceutical
  7.14.1 Jiangsu Nhwa Pharmaceutical Corporate Summary
  7.14.2 Jiangsu Nhwa Pharmaceutical Business Overview
  7.14.3 Jiangsu Nhwa Pharmaceutical Duloxetine Major Product Offerings
  7.14.4 Jiangsu Nhwa Pharmaceutical Duloxetine Revenue in Global Market (2017-2022)
  7.14.5 Jiangsu Nhwa Pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Duloxetine Market Opportunities & Trends in Global Market
Table 2. Duloxetine Market Drivers in Global Market
Table 3. Duloxetine Market Restraints in Global Market
Table 4. Key Players of Duloxetine in Global Market
Table 5. Top Duloxetine Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Duloxetine Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Duloxetine Revenue Share by Companies, 2017-2022
Table 8. Global Companies Duloxetine Product Type
Table 9. List of Global Tier 1 Duloxetine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Duloxetine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Duloxetine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Duloxetine Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Duloxetine Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Duloxetine Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Duloxetine Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Duloxetine Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Duloxetine Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Duloxetine Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Duloxetine Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Duloxetine Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Duloxetine Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Duloxetine Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Duloxetine Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Duloxetine Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Duloxetine Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Duloxetine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Duloxetine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Duloxetine Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Duloxetine Revenue, (US$, Mn), 2023-2028
Table 30. Eli Lilly Corporate Summary
Table 31. Eli Lilly Duloxetine Product Offerings
Table 32. Eli Lilly Duloxetine Revenue (US$, Mn), (2017-2022)
Table 33. Teva Corporate Summary
Table 34. Teva Duloxetine Product Offerings
Table 35. Teva Duloxetine Revenue (US$, Mn), (2017-2022)
Table 36. Lupin Corporate Summary
Table 37. Lupin Duloxetine Product Offerings
Table 38. Lupin Duloxetine Revenue (US$, Mn), (2017-2022)
Table 39. Sun Pharma Corporate Summary
Table 40. Sun Pharma Duloxetine Product Offerings
Table 41. Sun Pharma Duloxetine Revenue (US$, Mn), (2017-2022)
Table 42. Zydus Pharmaceuticals Corporate Summary
Table 43. Zydus Pharmaceuticals Duloxetine Product Offerings
Table 44. Zydus Pharmaceuticals Duloxetine Revenue (US$, Mn), (2017-2022)
Table 45. Torrent Pharmaceuticals Corporate Summary
Table 46. Torrent Pharmaceuticals Duloxetine Product Offerings
Table 47. Torrent Pharmaceuticals Duloxetine Revenue (US$, Mn), (2017-2022)
Table 48. Sandoz Corporate Summary
Table 49. Sandoz Duloxetine Product Offerings
Table 50. Sandoz Duloxetine Revenue (US$, Mn), (2017-2022)
Table 51. Aurobindo Pharma Corporate Summary
Table 52. Aurobindo Pharma Duloxetine Product Offerings
Table 53. Aurobindo Pharma Duloxetine Revenue (US$, Mn), (2017-2022)
Table 54. Apotex Corporate Summary
Table 55. Apotex Duloxetine Product Offerings
Table 56. Apotex Duloxetine Revenue (US$, Mn), (2017-2022)
Table 57. Breckenridge Corporate Summary
Table 58. Breckenridge Duloxetine Product Offerings
Table 59. Breckenridge Duloxetine Revenue (US$, Mn), (2017-2022)
Table 60. MACLEODS Corporate Summary
Table 61. MACLEODS Duloxetine Product Offerings
Table 62. MACLEODS Duloxetine Revenue (US$, Mn), (2017-2022)
Table 63. Ajanta Pharma Corporate Summary
Table 64. Ajanta Pharma Duloxetine Product Offerings
Table 65. Ajanta Pharma Duloxetine Revenue (US$, Mn), (2017-2022)
Table 66. CSPC Ouyi Pharm Corporate Summary
Table 67. CSPC Ouyi Pharm Duloxetine Product Offerings
Table 68. CSPC Ouyi Pharm Duloxetine Revenue (US$, Mn), (2017-2022)
Table 69. Jiangsu Nhwa Pharmaceutical Corporate Summary
Table 70. Jiangsu Nhwa Pharmaceutical Duloxetine Product Offerings
Table 71. Jiangsu Nhwa Pharmaceutical Duloxetine Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Duloxetine Segment by Type in 2021
Figure 2. Duloxetine Segment by Application in 2021
Figure 3. Global Duloxetine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Duloxetine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Duloxetine Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Duloxetine Revenue in 2021
Figure 8. By Type - Global Duloxetine Revenue Market Share, 2017-2028
Figure 9. By Application - Global Duloxetine Revenue Market Share, 2017-2028
Figure 10. By Region - Global Duloxetine Revenue Market Share, 2017-2028
Figure 11. By Country - North America Duloxetine Revenue Market Share, 2017-2028
Figure 12. US Duloxetine Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Duloxetine Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Duloxetine Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Duloxetine Revenue Market Share, 2017-2028
Figure 16. Germany Duloxetine Revenue, (US$, Mn), 2017-2028
Figure 17. France Duloxetine Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Duloxetine Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Duloxetine Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Duloxetine Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Duloxetine Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Duloxetine Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Duloxetine Revenue Market Share, 2017-2028
Figure 24. China Duloxetine Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Duloxetine Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Duloxetine Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Duloxetine Revenue, (US$, Mn), 2017-2028
Figure 28. India Duloxetine Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Duloxetine Revenue Market Share, 2017-2028
Figure 30. Brazil Duloxetine Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Duloxetine Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Duloxetine Revenue Market Share, 2017-2028
Figure 33. Turkey Duloxetine Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Duloxetine Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Duloxetine Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Duloxetine Revenue, (US$, Mn), 2017-2028
Figure 37. Eli Lilly Duloxetine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Teva Duloxetine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Lupin Duloxetine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sun Pharma Duloxetine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Zydus Pharmaceuticals Duloxetine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Torrent Pharmaceuticals Duloxetine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sandoz Duloxetine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Aurobindo Pharma Duloxetine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Apotex Duloxetine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Breckenridge Duloxetine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. MACLEODS Duloxetine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Ajanta Pharma Duloxetine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. CSPC Ouyi Pharm Duloxetine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Jiangsu Nhwa Pharmaceutical Duloxetine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)